1 Dec 2021 10:53 am
So what should it communicate to you if the FDA approved the Pfizer non-vaxx a year before the vaccine trials were even scheduled to conclude?
Particularly in light of its performance against the first variant to offer it a challenge.
Pfizer-BioNTech effectiveness down to 42% Moderna down to 76%